Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice

Lipids in Health and Disease

Research

Koji Nagao¹  Bungo Shirouchi²  Nao Inoue³  Teruyoshi Yanagita⁴  Masashi Inafuku⁵ 

[1] Department of Applied Biochemistry and Food Science, Saga University, 840-8502, Saga, Japan;Department of Applied Biochemistry and Food Science, Saga University, 840-8502, Saga, Japan;Department of Bioscience and Biotechnology, Kyushu University, 812-8581, Fukuoka, Japan;Department of Applied Biochemistry and Food Science, Saga University, 840-8502, Saga, Japan;Department of Food Function and Health, Tohoku University, 981-8555, Miyagi, Japan;Department of Applied Biochemistry and Food Science, Saga University, 840-8502, Saga, Japan;Department of Health and Nutrition Sciences, Nishikyushu University, 842-8585, Kanzaki, Japan;Department of Applied Biochemistry and Food Science, Saga University, 840-8502, Saga, Japan;Department of Mangroves and Bio-resources, University of the Ryukyus, 903-0213, Okinawa, Japan;

关键词: Panellus serotinus;    Atherogenic index;    Nonalcoholic fatty acid disease;    ob/ob;   

DOI  :  10.1186/1476-511X-12-18

 received in 2012-12-30, accepted in 2013-02-03,  发布年份 2013

来源: Springer

【 摘 要 】

BackgroundVarious mushrooms have been used in folk medicine for the treatment of lifestyle diseases in eastern countries, and several compounds that modulate the immune system, lower blood lipid levels, and inhibit tumor and viral action have been isolated. The fruiting body of Panellus serotinus (Mukitake) is recognized in Japan as one of the most delicious edible mushrooms, and previous studies have demonstrated that the dietary intake of powdered whole Mukitake or Mukitake extracts prevents the development of non-alcoholic fatty liver disease (NAFLD) in leptin-resistant db/db mice. In the present study, we evaluated the effect of the Mukitake diet on the pathogenesis of metabolic disorders in leptin-deficient ob/ob mice.ResultsAfter 4 weeks of feeding, hepatomegaly, hepatic lipid accumulation, and elevated hepatic injury markers in the serum were markedly alleviated in Mukitake-fed ob/ob mice compared with control mice. Moreover, the mild hyperlipidemia in control ob/ob mice was attenuated and the elevated atherogenic index was reduced in Mukitake-fed ob/ob mice. These effects were partly attributable to the suppression of hepatic lipogenic enzyme activity due to the Mukitake diet.ConclusionThe current results showed that Mukitake supplementation is beneficial for the alleviation of NAFLD and dyslipidemia in obese, diabetic ob/ob mice.

【 授权许可】

Unknown   
© Inoue et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.